BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Fananserin

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fananserin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ritanserin
20 shared targets
l
13 shared targets
spiroxatrine
14 shared targets
brexpiprazole
19 shared targets
niguldipine
18 shared targets
risperidone
18 shared targets
olanzapine
16 shared targets
spiperone
12 shared targets
ziprasidone
12 shared targets
paliperidone
12 shared targets
Loading evidence profile...

This evidence profile for Fananserin is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.